D
Arcturus Therapeutics Holdings Inc. ARCT
$18.51 $1.035.89% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income 46.68% 47.51% -156.30% 57.45% 67.24%
Total Depreciation and Amortization -14.30% -11.39% 0.49% 10.28% 23.34%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items -35.51% -34.10% -0.05% 5.39% 17.05%
Change in Net Operating Assets 84.43% -379.45% 1,287.50% -4.80% -125.09%
Cash from Operations 80.91% -532.32% 54.85% 26.67% -159.33%
Capital Expenditure 100.00% 42.92% 100.00% 91.85% 7.34%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -- -- -- -- --
Cash from Investing 100.00% 42.92% 100.00% 91.85% 7.34%
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock -88.60% -91.09% -90.02% -62.34% 2,456.38%
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash from Financing -712.82% 594.47% 100.72% -96.83% 2,456.38%
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 27.03% -456.39% 99.26% -100.49% -155.53%